Table 2 Site of infection and causative organisms in infected patients
n = 476 No. (%) | |
|---|---|
Infection site | |
Respiratory tract (HAP, VAP, empyema) | 242 (42.0) |
Intra-abdominal (peritonitis, biliary tract infection, abscess) | 42 (8.8) |
Cardiovascular (BSI, endocarditis, mediastinitis) | 88 (18.5) |
Soft tissue (erysipelas, phlebitis, abscess, decubitus infection) | 12 (2.5) |
Post-operative wound (superficial, deep) | 11 (2.3) |
Renal/urinary tract (urosepsis, upper urinary tract infection) | 9 (1.9) |
Central nervous system (brain abscess, meningitis) | 44 (9.2) |
Others (bones/joints, reproductive system, oral infections) | 14 (2.9) |
Unknown | 10 (2.1) |
Microorganisms | |
Gram-positive | 148 (31.0) |
Staphylococcus aureus | 38 (8.0) |
Staphylococcus epidermis | 26 (5.5) |
Streptococcus species | 10 (2.1) |
Enterococcus species | 65 (13.7) |
Other | 9 (1.9) |
Gram-negative | 139 (28.6) |
Enterobacteriaceae species | 68 (14.3) |
Haemophilus influenza | 18 (3.8) |
Pseudomonas species | 40 (8.4) |
Other | 13 (2.7) |
Other | 10 (2.1) |
Anaerobes | 6 (1.3) |
Unknown | 173 (36.3) |